| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |